Citation Impact
Citing Papers
The gut microbiota and host health: a new clinical frontier
2015 Standout
Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort
2009
Tryptophan catabolism in females with irritable bowel syndrome: relationship to interferon‐gamma, severity of symptoms and psychiatric co‐morbidity
2008
Non-alcoholic fatty liver and the gut microbiota
2016
Stability of person-specific blood-based infrared molecular fingerprints opens up prospects for health monitoring
2021 StandoutNobel
Microbiota in health and diseases
2022 Standout
Periodontal pathogenic bacteria, Aggregatibacter actinomycetemcomitans affect non-alcoholic fatty liver disease by altering gut microbiota and glucose metabolism
2017
Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease
2015
Characterization of the Gastrointestinal Microbiota in Health and Inflammatory Bowel Disease
2011
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
Microsatellite Instability in Colorectal Cancer
2010 Standout
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Specific gut microbiota features and metabolic markers in postmenopausal women with obesity
2015
Rheumatoid arthritis
2016 Standout
Microbial tryptophan catabolites in health and disease
2018 Standout
Ulcerative Colitis
2011 Standout
Brain–Gut Microbiome Interactions and Functional Bowel Disorders
2014
The scent of disease: volatile organic compounds of the human body related to disease and disorder
2011 Standout
Efficacy of Oral vs. Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Meta-Analysis
2011
Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics
2017 Standout
The Human Intestinal Microbiome in Health and Disease
2016 Standout
Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects?
2016
The Oslo definitions for coeliac disease and related terms
2012 Standout
Understanding the role of tryptophan and serotonin metabolism in gastrointestinal function
2009
Mechanisms and disease consequences of nonalcoholic fatty liver disease
2021
Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism
2018
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
Celiac Disease
2007 Standout
Targeted metabolomics and mass spectrometry
2010
Volatolomics in healthcare and its advanced detection technology
2022
Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?
2020
Gut microbiome and health: mechanistic insights
2022 Standout
Colorectal cancer
2019 Standout
Therapeutic Potential of Fecal Microbiota Transplantation
2013
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
2020
Noninvasive biomarkers in NAFLD and NASH — current progress and future promise
2018
Ulcerative colitis
2012 Standout
Non-alcoholic fatty liver disease
2021 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
2019 Standout
The role of the gut microbiota in NAFLD
2016
Gut–brain axis: how the microbiome influences anxiety and depression
2013 Standout
Significance of Erythema Nodosum and Pyoderma Gangrenosum in Inflammatory Bowel Diseases
2008
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
Dysbiosis in gastrointestinal disorders
2016
Metabolomics: the apogee of the omics trilogy
2012 Standout
European evidence-based Consensus on the management of ulcerative colitis: Special situations
2008
Metabolomics: beyond biomarkers and towards mechanisms
2016 Standout
The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
2014 Standout
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
2012
Ulcerative colitis
2016 Standout
Gastrointestinal flora and gastrointestinal status in children with autism – comparisons to typical children and correlation with autism severity
2011 Standout
Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders
2013 Standout
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
2016 Standout
Gut microbiome and liver diseases
2016
Duodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization
2011
Kynurenine pathway metabolism and the microbiota-gut-brain axis
2016
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
The Intestinal Microbiome in Nonalcoholic Fatty Liver Disease
2017
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
2018 Standout
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
2019 Standout
Faecal short-chain fatty acids - a diagnostic biomarker for irritable bowel syndrome?
2016
Interactions Between the Intestinal Microbiome and Liver Diseases
2014
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Gut microbiota in human metabolic health and disease
2020 Standout
The gut–liver axis and the intersection with the microbiome
2018
Gene-targeted microfluidic cultivation validated by isolation of a gut bacterium listed in Human Microbiome Project's Most Wanted taxa
2014
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta‐omics‐based approach
2016
Optical sensory arrays for the detection of urinary bladder cancer‐related volatile organic compounds
2018
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis
2016
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Gut Microbial Activity, Implications for Health and Disease: The Potential Role of Metabolite Analysis
2012
British Society of Gastroenterology position statement on serrated polyps in the colon and rectum
2017
Update on the Management of Refractory Coeliac Disease
2008
Highly sensitive room temperature sensors based on the UV-LED activation of zinc oxide nanoparticles
2008
The role of the gut microbiome in chronic liver disease: the clinical evidence revised
2019
Introduction to the human gut microbiota
2017 Standout
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
2008
Fine Pore‐Structure Engineering by Ligand Conformational Control of Naphthalene Diimide‐Based Semiconducting Porous Coordination Polymers for Efficient Chemiresistive Gas Sensing
2022 StandoutNobel
Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome
2018
The potential role of prebiotic fibre for treatment and management of non‐alcoholic fatty liver disease and associated obesity and insulin resistance
2011
Cladribine Therapy in Refractory Celiac Disease With Aberrant T Cells
2006
The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota
2017 Standout
Germline Mutations in Oncogene-Induced Senescence Pathways Are Associated With Multiple Sessile Serrated Adenomas
2013
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
The ecology of the microbiome: Networks, competition, and stability
2015 StandoutScience
How important is tryptophan in human health?
2017
11β-Hydroxysteroid Dehydrogenase 1: Translational and Therapeutic Aspects
2013
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis
2016
Metabolomics for Investigating Physiological and Pathophysiological Processes
2019
Updates in metabolomics tools and resources: 2014–2015
2015
Gut Microbiota and Host Reaction in Liver Diseases
2015
Discordant temporal development of bacterial phyla and the emergence of core in the fecal microbiota of young children
2015
Nanostructured Materials for Room‐Temperature Gas Sensors
2015 Standout
Decreased Bacterial Diversity Characterizes the Altered Gut Microbiota in Patients With Psoriatic Arthritis, Resembling Dysbiosis in Inflammatory Bowel Disease
2014
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
2016 Standout
MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights
2021 Standout
Works of Chris Probert being referenced
Identifying and quantifying metabolites by scoring peaks of GC-MS data
2014
Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease
2007
Diagnosis and treatment of pyoderma gangrenosum
2006
A Pilot Study Combining a GC-Sensor Device with a Statistical Model for the Identification of Bladder Cancer from Urine Headspace
2013
Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease
2013
An Investigation of Fecal Volatile Organic Metabolites in Irritable Bowel Syndrome
2013
An economic evaluation comparing concomitant oral and topical mesalazine versus oral mesalazine alone in mild-to-moderately active ulcerative colitis based on results from randomised controlled trial
2009
Are there any ethnic groups that are more likely to develop IBD?
2008
Urinary Volatile Organic Compounds for the Detection of Prostate Cancer
2015
Can 11β-Hydroxysteroid Dehydrogenase Activity Predict the Sensitivity of Bone to Therapeutic Glucocorticoids in Inflammatory Bowel Disease?
2011
Acute Tryptophan Depletion Alters Gastrointestinal and Anxiety Symptoms in Irritable Bowel Syndrome
2006
Best practice in the management of mild-to-moderately active ulcerative colitis and achieving maintenance of remission using mesalazine
2010
Prevalence of Different Subtypes of Serrated Polyps and Risk of Synchronous Advanced Colorectal Neoplasia in Average-Risk Population Undergoing First-Time Colonoscopy
2012
Refractory coeliac disease: remission with infliximab and immunomodulators
2005
Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial
2018
Analysis of Faecal Volatile Organic Compounds in Preterm Infants Who Develop Necrotising Enterocolitis: A Pilot Study
2009
Volatile organic compounds as diagnostic biomarkers in gastrointestinal and liver diseases.
2009
1097 Once-Daily Versus Twice-Daily Mesalazine for Active Ulcerative Colitis: Efficacy Results From MOTUS, a Multicentre, Controlled, Randomised, Investigator-Blinded Study
2012
One-year investigator-blind randomized multicenter trial comparing asacol 2.4 g once daily with 800 mg three times daily for maintenance of remission in ulcerative colitis
2011